- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03658954
Multimodal Sleep Intervention Using Wearable Technology
November 10, 2023 updated by: Yale University
Development of a Multimodal Sleep Intervention Using Wearable Technology to Reduce Heavy Drinking in Young Adults
This research study is examining three different components of a mobile sleep intervention: web-based sleep hygiene advice, sleep and alcohol diary self-monitoring, and personalized sleep and alcohol consumption feedback.
The study is designed to find out which of these components are most effective for mitigating alcohol use disorders and improving sleep quality among young adults.
The study has three parts: 1) an intake session; 2) a 2-week treatment phase; and 3) three follow-up visits over the next 10 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Targeting sleep concerns may be a novel strategy for reducing increased risk of alcohol use disorders in young adults.
The current study will develop and test a mobile intervention addressing sleep concerns in 120 heavy-drinking young adults.
All participants will wear sleep and alcohol trackers daily.
Participants will be randomized to one of three interventions.
The primary intervention (60 participants) will include web-based sleep hygiene advice + sleep/alcohol diary self-monitoring + sleep/alcohol data feedback.
The comparison interventions will be compared to matched control conditions only including these components: (1) web-based sleep hygiene advice (30 participants) or (2) web-based sleep hygiene advice + sleep/alcohol diary self-monitoring (30 participants).
The primary objective is to evaluate sleep intervention component feasibility, acceptability, and preliminary efficacy on alcohol outcomes to inform a Stage II randomized trial comparing the final sleep intervention with a standard alcohol intervention.
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06511
- Yale University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18-25 years of age;
- report ≥ 3 heavy drinking occasions in the last 2 weeks (i.e., ≥5 drinks on 1 occasion for men; ≥4 for women);
- report having concerns about their sleep;
- willing/able to complete daily sleep diaries and wear sleep and alcohol trackers;
- report Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) scores indicative of risk of harm from drinking (i.e., ≥7 and ≥5 for men and women, respectively)
- read and understand English;
- have a smartphone that can be used to sync tracker data. An estimated 86% of young adults own a smartphone.
Exclusion Criteria:
- history of a sleep disorder;
- night or rotating shift work; travel beyond 2 time zones in month prior and/or planned travel beyond 2 time zones during study participation;
- meet criteria for an alcohol use disorder in the past 12 months that is clinically severe defined by: a) a history of seizures, delirium, or hallucinations during alcohol withdrawal; b) report drinking to avoid withdrawal symptoms or have had prior treatment of alcohol withdrawal; c) have required medical treatment of alcohol withdrawal in the past 6 months;
- currently enrolled in alcohol or sleep treatment;
- exhibit current psychiatric illness (i.e., bipolar disorder, schizophrenia, major depression, panic disorder, borderline personality disorder, organic mood or mental disorders, or suicide or violence risk) by history or psychological examination;
- current DSM-V substance use disorder or a positive urine drug screen for opiates, cocaine, barbiturates, benzodiazepines, amphetamines, or phencyclidine.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Advice
Participants receive only web-based sleep hygiene advice
|
Once per week for two weeks, participants will come to in-person visits to receive brief web-based sleep hygiene advice.
|
Experimental: Advice + Self-monitoring
Participants receive web-based sleep hygiene advice + sleep/alcohol diary self-monitoring
|
Once per week for two weeks, participants will come to in-person visits to receive brief web-based sleep hygiene advice.
Participants will complete daily web-based sleep and alcohol diaries for two weeks.
|
Experimental: Advice + Self-monitoring + Feedback
Participants receive web-based sleep hygiene advice + sleep/alcohol diary self-monitoring + sleep/alcohol data feedback
|
Once per week for two weeks, participants will come to in-person visits to receive brief web-based sleep hygiene advice.
Participants will complete daily web-based sleep and alcohol diaries for two weeks.
Participants will receive feedback once per week for two weeks on their sleep and alcohol consumption, using all possible data derived from Fitbit actigraphs and Milo Sensor blood-alcohol trackers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Alcohol Drinks Consumed Over the 12wk Followup
Time Frame: weeks 4 through 12
|
This will be recorded using the Timeline Follow-back Interview, based on the U.S. Standard Drink Conversion Chart.
Upon results entry, the outcome was updated to include the following: data are log-transformed total alcohol drinks consumed over time from Week 4 to Week 12 follow-up, controlling for baseline.
|
weeks 4 through 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
National Institutes of Health Patient-Reported Outcomes Measurement Information System™ (NIH PROMIS™) Sleep Disturbance Score- Least Squares Mean Across Assessments
Time Frame: Baseline, week 4, week 8 and week 12
|
This is a validated, reliable measure of perceived sleep quality/satisfaction and difficulty initiating/maintaining sleep.
Upon results entry, the outcome was updated to reflect the following: Sleep Disturbance Score assessed at Week 4, 8 and 12, controlling for baseline.
Scores represent standardized T scores with mean of 50 and a standard deviation of 10.
Higher scores, 50 and above, equal greater sleep disturbance.
Scores 60 and above are clinically significant.
Presented is the least squares mean across assessments.
|
Baseline, week 4, week 8 and week 12
|
National Institutes of Health Patient-Reported Outcomes Measurement Information System™ (NIH PROMIS™) Sleep-Related Impairment Score - Least Squares Mean Across Assessments
Time Frame: Baseline, week 4, week 8 and week 12
|
National Institutes of Health Patient-Reported Outcomes Measurement Information System™ (NIH PROMIS™) Sleep-Related Impairment Score assessed at Week 4, 8, and 12, controlling for baseline.
Scores represent standardized T scores with mean of 50 and a standard deviation of 10.
Higher scores, 50 and above, equal greater sleep-related impairment.
Scores 60 and above are clinically significant.
Presented is the least squares mean across assessments.
|
Baseline, week 4, week 8 and week 12
|
End of Treatment Satisfaction Survey Score
Time Frame: 2 weeks
|
In this survey, participants will rate their satisfaction associated with each intervention component using a 5-point Likert-type scale.
Upon results entry, the outcome was corrected to reflect the following: the overall treatment satisfaction uses the mean of questions on a 5-point Likert-type scale from 0 to 4, with higher scores indicating greater satisfaction.
|
2 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stop-signal Reaction Time
Time Frame: 4 weeks
|
The difference between the mean reaction time and the stop-signal delay on the stop-signal test.
Upon results entry, the following was added: This outcome will be explored as a potential mechanism of sleep intervention condition effects on the primary outcome of total drinks consumed.
If there is a significant effect of condition on total drinks, the analysis of stop signal reaction time will be conducted.
Due to COVID-19, this assessment was stopped since it could not be administered virtually.
Since there was no effect of condition on total drinks consumed, an analysis of this outcome as a potential mechanism was not undertaken.
The following represents the number of participants in each condition had this assessment conducted prior to COVID.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 7, 2018
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
August 31, 2018
First Submitted That Met QC Criteria
August 31, 2018
First Posted (Actual)
September 6, 2018
Study Record Updates
Last Update Posted (Estimated)
November 13, 2023
Last Update Submitted That Met QC Criteria
November 10, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2000021048
- R34AA026021 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drinking, Alcohol
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
Boston University Charles River CampusRecruiting
-
University of ArkansasRecruitingDrinking Behavior | Drinking Excessive | DrinkingUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruiting
-
Universidad de GranadaCompletedExercise | Drinking, AlcoholSpain
-
University of North Texas Health Science CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
University of MinnesotaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Michigan and other collaboratorsCompleted
Clinical Trials on Advice
-
VU University of AmsterdamAmsterdam UMC, location VUmc; University of HelsinkiCompletedPhysical Disability | Protein-Energy MalnutritionFinland, Netherlands
-
Basque Health ServiceUnknownObesity | OverweightSpain
-
University of ReadingCompletedDietary Habits | Dietary ModificationUnited Kingdom
-
University of ReadingCompletedDietary Habits | Dietary ModificationKuwait, United Kingdom
-
Milton S. Hershey Medical CenterWithdrawnCardiovascular DiseasesUnited States
-
Centre Hospitalier Universitaire de BesanconHospices Civils de Lyon; University Hospital, Strasbourg, France; University... and other collaboratorsUnknownOut of Hospital Cardiac ArrestFrance
-
University Hospital, MontpellierHôpital Necker-Enfants MaladesCompletedLanguage Development
-
Oslo Metropolitan UniversityNorwegian Labour and Welfare AdministrationActive, not recruitingMusculoskeletal Pain | Musculoskeletal DiseaseNorway
-
St Mary's University CollegeUnknown
-
Copenhagen University Hospital at HerlevCompleted